Results for tag: "Hemochromatosis Drug"

Hemochromatosis is a genetic disorder that causes the body to absorb and store too much iron. Hematological drugs are used to treat this condition by reducing the amount of iron in the body. These drugs work by binding to iron in the body and preventing it from being absorbed. Commonly used drugs include deferoxamine, deferiprone, and deferasirox. These drugs are administered either orally or intravenously, depending on the severity of the condition. The hemochromatosis drug market is a niche market, with a limited number of drugs available. The market is highly competitive, with several companies offering similar products. Companies in the market include Novartis, Pfizer, Sanofi, and GlaxoSmithKline. Show Less Read more